Glargine Versus NPH in Patients With Chronic Kidney Disease

NCT02451917 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Chronic Kidney Disease

Interventions

DRUG: Glargine insulin
DRUG: NPH insulin

Sponsor

University of Sao Paulo General Hospital